Prostate cancer detection using quantitative T<sub>2</sub> and T<sub>2</sub>‐weighted imaging: The effects of 5‐alpha‐reductase inhibitors in men on active surveillance
Francesco Giganti(University College Hospital), Alex Kirkham, Brandon Whitcher(Royal Marsden NHS Foundation Trust), Mathias Winkler(National Health Service), Simon Bott(Prostate Cancer Research), Ramiro Castro‐Santamaria(GlaxoSmithKline (United States)), Neil McCartan(University College London), Charles Jameson(Royal London Hospital), Mark Emberton(University College London), Nicola L. Robertson(University College London Hospitals NHS Foundation Trust), Giulio Gambarota(Inserm), Clare Allen(St Peter's Hospital), Caroline M. Moore(University College London Hospitals NHS Foundation Trust)
Cited by 22
Related Papers
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
|The Lancet|2017|3.2k
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
An Introduction to Wavelets and Other Filtering Methods in Finance and Economics
|Elsevier eBooks|2002|1.1k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694